Redsense Medical AB (publ) (XSAT:REDS)
Sweden
· Delayed Price · Currency is SEK 3.100
-0.170 (-5.20%)
At close: Mar 6, 2026
Redsense Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 26.8 | 28.77 | 25.52 | 16.75 | 16.34 | Upgrade
|
| Other Revenue | -0 | - | - | 0 | - | Upgrade
|
| Revenue | 26.8 | 28.77 | 25.52 | 16.75 | 16.34 | Upgrade
|
| Revenue Growth (YoY) | -6.84% | 12.74% | 52.32% | 2.51% | -4.43% | Upgrade
|
| Cost of Revenue | 11.24 | 10.69 | 12.36 | 5.49 | 5.95 | Upgrade
|
| Gross Profit | 15.56 | 18.08 | 13.16 | 11.27 | 10.4 | Upgrade
|
| Selling, General & Admin | 18.66 | 19.76 | 17.54 | 22.46 | 22.77 | Upgrade
|
| Other Operating Expenses | 3.65 | -1.96 | 0.59 | -1.04 | -0.56 | Upgrade
|
| Operating Expenses | 22.93 | 17.87 | 18.2 | 21.47 | 22.39 | Upgrade
|
| Operating Income | -7.37 | 0.21 | -5.04 | -10.21 | -11.99 | Upgrade
|
| Interest Expense | - | -0.04 | -0.03 | -0.1 | -0.05 | Upgrade
|
| Interest & Investment Income | 0.2 | 0.17 | 0.06 | 1.02 | 1.05 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -0.3 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | 2.5 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | - | - | -0 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -7.17 | 0.34 | -5.01 | -6.79 | -11.29 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.5 | -1.97 | 3.32 | Upgrade
|
| Pretax Income | -7.17 | 0.34 | -4.51 | -8.76 | -7.97 | Upgrade
|
| Net Income | -7.17 | 0.34 | -4.51 | -8.76 | -7.97 | Upgrade
|
| Net Income to Common | -7.17 | 0.34 | -4.51 | -8.76 | -7.97 | Upgrade
|
| Shares Outstanding (Basic) | 16 | 17 | 14 | 14 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 17 | 14 | 14 | 14 | Upgrade
|
| Shares Change (YoY) | -3.83% | 21.25% | -0.16% | 0.60% | - | Upgrade
|
| EPS (Basic) | 0.44 | 0.02 | -0.32 | -0.62 | -0.57 | Upgrade
|
| EPS (Diluted) | 0.44 | 0.02 | -0.32 | -0.62 | -0.57 | Upgrade
|
| EPS Growth | 2100.00% | - | - | - | - | Upgrade
|
| Free Cash Flow | -5.24 | -8.25 | -5.1 | -9.83 | -12.58 | Upgrade
|
| Free Cash Flow Per Share | -0.32 | -0.48 | -0.36 | -0.70 | -0.90 | Upgrade
|
| Gross Margin | 58.07% | 62.83% | 51.56% | 67.24% | 63.63% | Upgrade
|
| Operating Margin | -27.48% | 0.73% | -19.74% | -60.93% | -73.37% | Upgrade
|
| Profit Margin | -26.76% | 1.19% | -17.69% | -52.27% | -48.78% | Upgrade
|
| Free Cash Flow Margin | -19.54% | -28.66% | -20.00% | -58.68% | -76.98% | Upgrade
|
| EBITDA | -6.74 | 0.28 | -4.98 | -10.16 | -11.97 | Upgrade
|
| EBITDA Margin | -25.14% | 0.96% | -19.50% | -60.61% | -73.21% | Upgrade
|
| D&A For EBITDA | 0.63 | 0.07 | 0.06 | 0.05 | 0.03 | Upgrade
|
| EBIT | -7.37 | 0.21 | -5.04 | -10.21 | -11.99 | Upgrade
|
| EBIT Margin | -27.48% | 0.73% | -19.74% | -60.93% | -73.37% | Upgrade
|
| Revenue as Reported | 26.8 | 32.63 | 25.56 | 17.79 | 16.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.